What is atherosclerosis
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Understanding Atherosclerosis: Pathophysiology, Inflammation, and Risk Factors
Introduction to Atherosclerosis
Atherosclerosis is a chronic disease of the arterial wall and a leading cause of cardiovascular diseases (CVD), which are the primary cause of mortality worldwide . It is characterized by the accumulation of lipids, fibrous elements, and calcification within the arterial walls, leading to vessel narrowing and the activation of inflammatory pathways.
Pathophysiology of Atherosclerosis
Endothelial Dysfunction and Lipid Accumulation
The initiation of atherosclerosis begins with endothelial dysfunction, which is often triggered by factors such as hyperlipidemia, hypertension, diabetes, and smoking. This dysfunction leads to the accumulation of apolipoprotein-B-containing lipoproteins in the subendothelial space, which then acquire features of damage-associated molecular patterns. These lipoproteins trigger an innate immune response dominated by monocyte-macrophages, followed by an adaptive immune response.
Chronic Inflammation and Immune Response
Atherosclerosis is fundamentally a chronic inflammatory disease. Unlike acute inflammation, which is self-limiting, atherosclerosis represents an unresolved inflammatory condition. The failure to switch from a pro-inflammatory to a pro-resolving phase results in the continuous recruitment of inflammatory cells, leading to chronic inflammation and arterial damage . Immune cells, including macrophages, dendritic cells, and lymphocytes, play crucial roles in the progression of atherosclerotic lesions.
Molecular and Cellular Mechanisms
Role of MicroRNAs and Epigenetics
Emerging evidence suggests that microRNAs and other epigenetic mechanisms, such as DNA methylation and histone modification, significantly influence the progression and vulnerability of atherosclerotic plaques . These epigenetic changes can modulate the expression of genes involved in inflammation and lipid metabolism, highlighting the potential for epigenetic therapies in treating atherosclerosis.
Inflammatory Pathways and Oxidative Stress
Under proatherogenic conditions, the production of nitric oxide from endothelial cells is reduced, while the burden of reactive oxygen species (ROS) and advanced glycation end products (AGE) is increased. This oxidative stress further exacerbates endothelial dysfunction and inflammation. Targeting ROS-generating enzymes and inflammatory adhesion molecules has shown beneficial effects in reducing atherosclerosis.
Clinical Implications and Risk Factors
Plaque Formation and Rupture
The formation of atheroma plaques is a hallmark of atherosclerosis. These plaques consist of a lipid-rich core and a fibrous cap. Plaque rupture, characterized by a thin fibrous cap and a large lipid core, is the most common cause of coronary thrombosis, leading to acute cardiovascular events such as heart attacks and strokes. Detecting and preventing the rupture of these plaques is crucial for managing atherosclerosis.
Environmental and Genetic Risk Factors
Epidemiological studies have identified several environmental and genetic risk factors associated with atherosclerosis. These include high levels of low-density lipoprotein (LDL) cholesterol, hypertension, diabetes, smoking, and genetic predispositions. Understanding these risk factors is essential for developing preventive and therapeutic strategies.
Conclusion
Atherosclerosis is a complex, chronic inflammatory disease driven by lipid accumulation, endothelial dysfunction, and unresolved inflammation. The interplay between genetic, environmental, and epigenetic factors further complicates its pathogenesis. Continued research into the molecular mechanisms and immune responses involved in atherosclerosis is vital for developing effective treatments and reducing the global burden of cardiovascular diseases.
Sources and full results
Most relevant research papers on this topic